Electro Optic Systems Holdings Limited (ASX:EOS) secured two deals totalling A$4.25 million under which the Company would be supplying R400 Remote Weapon Systems to a European NATO country. A number of these systems would be used for integration onto Remotely Operated Combat Vehicles and include the remote-control units to run the systems. The delivery of both deals shall be accomplished in the current calendar year 2020.
The Australian Prudential Regulation Authority (APRA) and the Australian Competition and Consumer Commission (ACCC) have signed an updated MoU intended to encourage closer cooperation between the two regulators. The new MoU gives both agencies a broader model of engagement with more emphasis on proactive sharing of information and collaboration. In order to increase transparency, it has been written in a simpler and less prescriptive language. The revised MoU shall also help in strengthening the relationship between the two agencies.
ASX 200 listed global leader in allogeneic cellular medicines, Mesoblast Limited (ASX:MSB) disclosed that its lead drug contender remestemcel-L had been nominated as the winner of the Fierce Innovation Awards for Biotech Innovation (Life Sciences Edition 2020). The Fierce Innovation Awards is a peer-reviewed program from FiercePharma and FierceBiotech publisher.